$1.02 Earnings Per Share Expected for Innospec Inc. (IOSP) This Quarter

Equities analysts expect Innospec Inc. (NASDAQ:IOSP) to report earnings of $1.02 per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Innospec’s earnings. Innospec reported earnings of $1.00 per share during the same quarter last year, which would indicate a positive year over year growth rate of 2%. The business is scheduled to issue its next quarterly earnings results after the market closes on Tuesday, November 6th.

According to Zacks, analysts expect that Innospec will report full-year earnings of $4.35 per share for the current financial year. For the next year, analysts anticipate that the company will report earnings of $4.75 per share. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that follow Innospec.

Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, August 7th. The specialty chemicals company reported $1.00 EPS for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.05). Innospec had a return on equity of 13.83% and a net margin of 4.45%. The business had revenue of $358.10 million for the quarter.

A number of equities research analysts recently issued reports on the company. BidaskClub cut Innospec from a “buy” rating to a “hold” rating in a research note on Saturday, August 4th. Zacks Investment Research upgraded Innospec from a “sell” rating to a “hold” rating in a research note on Wednesday, September 19th. KeyCorp boosted their price objective on Innospec from $80.00 to $86.00 and gave the company an “overweight” rating in a research note on Friday, July 13th. Finally, ValuEngine cut Innospec from a “buy” rating to a “hold” rating in a research note on Friday, October 12th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $85.50.

Shares of Innospec stock opened at $68.42 on Friday. Innospec has a 52-week low of $60.50 and a 52-week high of $83.20. The stock has a market capitalization of $1.70 billion, a P/E ratio of 14.68 and a beta of 0.96. The company has a current ratio of 2.28, a quick ratio of 1.34 and a debt-to-equity ratio of 0.26.

A number of hedge funds have recently bought and sold shares of IOSP. Northern Trust Corp grew its holdings in Innospec by 0.8% during the 1st quarter. Northern Trust Corp now owns 497,741 shares of the specialty chemicals company’s stock valued at $34,145,000 after buying an additional 3,984 shares in the last quarter. Great West Life Assurance Co. Can grew its holdings in Innospec by 4.2% during the 1st quarter. Great West Life Assurance Co. Can now owns 32,132 shares of the specialty chemicals company’s stock valued at $2,205,000 after buying an additional 1,309 shares in the last quarter. Profund Advisors LLC grew its holdings in Innospec by 21.4% during the 1st quarter. Profund Advisors LLC now owns 4,452 shares of the specialty chemicals company’s stock valued at $305,000 after buying an additional 786 shares in the last quarter. UBS Group AG grew its holdings in Innospec by 69.3% during the 1st quarter. UBS Group AG now owns 2,771 shares of the specialty chemicals company’s stock valued at $190,000 after buying an additional 1,134 shares in the last quarter. Finally, Barclays PLC grew its holdings in Innospec by 19.0% during the 1st quarter. Barclays PLC now owns 8,572 shares of the specialty chemicals company’s stock valued at $588,000 after buying an additional 1,367 shares in the last quarter. 92.92% of the stock is owned by institutional investors and hedge funds.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

Recommended Story: Conference Calls

Get a free copy of the Zacks research report on Innospec (IOSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply